Medical Assessor

Job summary

We are currently looking forMedical Assessorsto join our Innovative Medicines within theHealthcare, Quality and Accessgroup.

These arefull-timeopportunities,on apermanentbasis.The roles will be based in 10 South Colonnade, Canary Wharf London.

Government departments and agencies are working towards implementing a minimum 60% attendance in office sites.

We are currently implementing a flexible, hybrid way of working, with a minimum of 8 days per month working on site to enable the collaboration and contact with partners and stakeholders needed to deliver MHRA business. Attendance on site is driven by business needs so depending on the nature of the role, this can flex up to 12 days a month, with the remainder of time worked either remotely or in the office. Some roles will need to be on site more regularly.

Please be aware that this role can only be worked in the UK and not overseas.

Main duties of the job

The successful candidate will be reporting to the Head of an Assessment Unit in Innovative Medicines. You will be required to assess the clinical and regulatory aspects of marketing authorisation applications forchemical or biological products, in a variety of therapeutic fields.

You will develop and maintain good working relationships with external stakeholders including dealing effectively with official correspondence to agreed timelines. You will contribute to and influence assessment policy and practice, and proactively identify where such contributions would be beneficial.

About us

The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.

The objective of the Innovative Medicines team in Healthcare, Quality and Access Group is to drive quality and critically appraise benefits and risks to inform robust decisions on healthcare access including accelerated access pathways. It will do this by bringing together a fusion of our capabilities across both medicines and medical devices to enable licensing and market access, as well as ensuring compliance with regulations and standards.